Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study

This study evaluated the efficacy and safety of tadalafil in pediatric patients with pulmonary arterial hypertension. This phase‐3, international, randomized, multicenter (24 weeks double‐blind placebo‐controlled period; two‐year, open‐labeled extension period), add‐on (patient’s current endothelin...

Full description

Bibliographic Details

Published in:	Pulmonary Circulation
Main Authors:	Dunbar Ivy, Damien Bonnet, Rolf Berger, Gisela M.B. Meyer, Simin Baygani, Baohui Li, the LVHV Study Group
Format:	Article
Language:	English
Published:	Wiley 2021-07-01
Subjects:	pulmonary arterial hypertension hypertension pulmonary biomarkers risk factors
Online Access:	https://doi.org/10.1177/20458940211024955